Concepedia

Yosuke Ogoshi

YO

Statistics

Publications

7

Citations

166

H-Index

7

Active since

2004

Affiliations

Japan Tobacco (Japan)(Current)

Tohoku University

Array BioPharma (United States)

Yosuke Ogoshi is an author at Japan Tobacco (Japan) specializing in medicinal chemistry, drug discovery, and pharmacy.

ORCID

Publications per year

2004–2021

7

Publications

7

Discovery of JTZ-951: A HIF Prolyl Hydroxylase Inhibitor for the Treatment of Renal Anemia

Yosuke Ogoshi, Takuya Matsui, Ikuo MITANI et al. · ACS Medicinal Chemistry Letters · 2017 · 52 citations · Full text

, , +13

Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity

Minoru Ubukata, Ikuo MITANI, Yuichi Nakagawa et al. · European Journal of Medicinal Chemistry · 2018 · 30 citations · Full text

, , +13

Design, synthesis, and structure–activity relationship of new isobenzofuranone ligands of protein kinase C

Yoshiyasu Baba, Yosuke Ogoshi, Go Hirai et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 26 citations · Full text

, , +15

Synthesis and SAR of 2-phenyl-1-sulfonylaminocyclopropane carboxylates as ADAMTS-5 (Aggrecanase-2) inhibitors

Makoto Shiozaki, Hiroto Imai, Katsuya Maeda et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 19 citations · Full text

, , +5

Novel N-substituted 2-phenyl-1-sulfonylamino-cyclopropane carboxylates as selective ADAMTS-5 (Aggrecanase-2) inhibitors

Makoto Shiozaki, Katsuya Maeda, Tomoya Miura et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 17 citations · Full text

, , +6

1–5 of 7